Secrecy over CFCs in medical aerosols

The Government has refused to disclose the identity of most medical aerosol products which still contain chlorofluorocarbons (CFCs) or their manufacturers on the grounds of commercial confidentiality.

Medical aerosols account for a small proportion of CFC consumption and there has been little pressure to eliminate them from these applications on ozone depletion grounds because they are generally regarded as vital to safeguarding human health. The common perception has been that remaining CFC usage in this sector is in inhalant drugs for treating asthma and other respiratory problems. However, it now appears that CFCs are still being used in

Please sign in or register to continue.

Sign in to continue reading

Having trouble signing in?

Contact Customer Support at
report@ends.co.uk
or call 020 8267 8120

Subscribe for full access

or Register for limited access

Already subscribe but don't have a password?
Activate your web account here